Document is current

Article History

Accepted: 4 October 2024

First Online: 20 November 2024

Declarations

:

: S. Kluge received research support from Cytosorbents and Daiichi Sankyo. He also received lecture fees from ADVITOS, Biotest, CSL Behring, Daiichi Sankyo, Fresenius Medical Care, Gilead, Mitsubishi Tanabe Pharma, MSD, Pfizer, Shionogi and Zoll. He received consultant fees from ADVITOS, Fresenius, Gilead, MSD and Pfizer. T. Staudinger: Lecture fees from Xenios, Getinge, Baxter, Mitsubishi Pharma, AOP, Fresenius. C. Karagiannidis declares that he has no competing interests.

: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.

: The supplement containing this article is not sponsored by industry.

Free to read: This content has been made available to all.